Health Canada drug identification number

DIN 02221292 — TEVA-MEDROXYPROGESTERONE 5 MG

TEVA-MEDROXYPROGESTERONE is a tablet of Medroxyprogesterone acetate marketed by TEVA CANADA LIMITED. The full Medroxyprogesterone acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02221292
Brand name
TEVA-MEDROXYPROGESTERONE
Strength
5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Progestin (progestogen) hormone

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Medroxyprogesterone acetate products

DINBrandStrengthFormManufacturerStatus
02277298 AA-MEDROXY 10 MG TABLET AA PHARMA INC MARKETED
02267640 AA-MEDROXY 100 MG TABLET AA PHARMA INC MARKETED
02244726 AA-MEDROXY 2.5 MG TABLET AA PHARMA INC MARKETED
02244727 AA-MEDROXY 5 MG TABLET AA PHARMA INC MARKETED
02523493 DEPO-PROVERA 150 MG SUSPENSION PFIZER CANADA ULC MARKETED
02221306 TEVA-MEDROXYPROGESTERONE 10 MG TABLET TEVA CANADA LIMITED MARKETED
02221284 TEVA-MEDROXYPROGESTERONE 2.5 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.